This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The $13,759.61 firm fixed price delivery order (SPE2DB20D2104|SPE2DB25FMEJG) was awarded on December 17, 2024, with a performance period through December 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides medical products to various federal agencies, including the DLA, which supports military healthcare programs globally. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for supplying a comprehensive range of pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/18/25, 9:51 AM